“RENAL AND HEPATIC IMPAIRMENT BROUGHT ON BY CISPLATIN WITHOUT COMPROMISING ANTICANCER EFFICACY”., RJDNMD, vol. 31, no. 1, pp. 394–406, Mar. 2024, Accessed: May 18, 2024. [Online]. Available: https://jrdiabet.ro/index.php/RJDNMD/article/view/307